Outsourced Pharma App Notes & Case Studies

1. Controlling mAb Aggregates In Chromatography Process Development 5/22/2026

   Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Explore why aggregates form, why they matter, and how chromatographic strategies can help reduce risk.

2. Residence Time Of Powders In Tablet Compression 7/30/2024

   Knowing how formulation moves through a tablet process is invaluable in optimizing the process for the greatest tablet quality and production.

3. Mitigating Powder Flow And Static Issues Using SYLOID® Mesoporous Silica 10/7/2025

   See how incorporating small amounts of mesoporous silica during micronization can significantly enhance powder flow, thereby making subsequent blending and formulation more efficient and consistent.

4. Fab-Oligo Conjugation 8/25/2025

   Explore a platform process towards the production of Fab-siRNA conjugates that proves to be scalable and efficient. Find out more about how bioconjugation services can improve your discovery program.

5. Time-To-Manufacture Reduced By 30% Through Rapid Transfer Strategy 12/2/2025

   Critical formulation deficiencies were solved through rapid batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.

6. Enhanced Flow Kit Performance With Leak And PUPSIT Testing 1/13/2026

   Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.

7. Discover A System That Can Be Used With Various Cell Culture Media 6/19/2026

   Evolving CAR T cell therapies are raising the bar for manufacturing. Advances in cell expansion and the shift to serum-free media are redefining how scalable, future-ready processes are designed.

8. Improving CD Media Titers With Nu-Tek Peptones 4/17/2026

   Adding 0.2% soy peptone to chemically defined media increases CHO IgG production by 30–60%. This animal-free supplementation enhances titers while maintaining high process control.

9. Formulation Development For Therapeutic Oligonucleotides 6/10/2025

   Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

10. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

    Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.